Stability of Essential Drugs in Tropical Climates: Zimbabwe - EDM Research Series No. 013
(1994; 86 pages) Voir le document au format PDF
Table des matières
Afficher le documentAbbreviations
Afficher le document1. Summary
Ouvrir ce répertoire et afficher son contenu2. Introduction
Ouvrir ce répertoire et afficher son contenu3. Study design and methods
Afficher le document4. Results
Ouvrir ce répertoire et afficher son contenu5. Discussion
Ouvrir ce répertoire et afficher son contenu6. Conclusions and recommendations
Afficher le documentReferences
Fermer ce répertoireAnnexes
Fermer ce répertoireAnnex 1: Detailed results for each drug
Afficher le document1.1 Amoxycillin capsules
Afficher le document1.2 Ampicillin capsules
Afficher le document1.3 Acetylsalicylic acid tablets
Afficher le document1.4 Doxycycline capsules
Afficher le document1.5 Ferrous sulfate tablets
Afficher le document1.6 Phenoxymethylpenicillin tablets
Afficher le document1.7 Tetracycline capsules
Afficher le document1.8 Retinol tablets
Afficher le document1.9 Epinephrine injection
Afficher le document1.10 Ampicillin injection
Afficher le document1.11 Benzylpenicillin injection
Afficher le document1.12 Ergometrine injection
Afficher le document1.13 Procaine penicillin injection
Afficher le documentAnnex 2: Validation of laboratory results
 

1.13 Procaine penicillin injection

SHELF LIFE

Manufacturer A: 2 years

ASSAY METHOD

Spectrophotometric method, BP 1988 p, 840/Addendum 1989. Contents of 10 vials mixed and measured three times; mean taken.

ASSAY LIMITS

90 - 110% (BP)

SAMPLES OBTAINED

Manufacturer A

GMS samples

no.

%

Total

25

100

Harare

16

64

Bulawayo

9

36

Facility samples

no.

%

Total

72

100

Age > 50% SLife

2

3

Facility type = PCH

58

81

Climate = hot

53

74

Transport = slow

46

64

Longitudinal series

   

Total

42

100

SUMMARY ASSAY RESULTS

GMS samples

All Manuf.

     

Mean age (mths)

 

1.5

     

Mean assay

 

101.0%

     

95% CL

99.3 - 102.8%

     

Mo. and % fail

0

0%

     

No. and % low fail

2

3%

     

No. and % high fail

0

0%

     

Facility samples

Manufacturer A

     

Mean age (mths)

 

6.0

     

Mean assay

 

98.3%

     

95% CL

96.9 - 99.7%

     

No. and % fail

3

4%

     

No, and % low fail

2

11%

     

No. and % high fail

0

0%

     

Longitudinal series

at manufacturer

at GMS

at facility

Mean age (mths)

 

0

 

1.4

57

Mean assay

 

101.2%

 

101.2%

97.3%

95% CL

100.2 - 102.1%

99.9 - 102.6%

95.3 - 99.4%

No, and % fail

0

0%

0

0%

3

7%

 

Mean interval (mths)

4.3

 

Mean loss (-) or gain (+)

-3.6%

 

95% CL for loss/gain

-6.3 to -0.9%


Figure 1 - Results of GMS samples


Figure 2 - Results of facility samples

Findings:

a) No expired samples were found.

b) All 25 GMS samples were within assay limits (mean 101.0%). There was one borderline sample (92.0%).

c) Three of 72 facility samples (4%) failed; all failures were below the lower limit (72.2, 83.0, 85.0%). All three failures were from the same batch, the same geographical area and were transported by rail.

d) 42 GMS/facility sample pairs showed a mean loss of potency (-3.6%); the difference was statistically significant (t-test one tail, p=0.0001).

e) No initial quality problem was found.

f) A modest instability problem was seen. Since the samples were in the early part of shelf-life, this is potentially more serious.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013